Ocrevus (Ocrelizumab)Medication Precertification Request

GR-69329 (3-18) Page 1 of 3 Ocrevus ( ocrelizumab ) medication Precertification Request Aetna Precertification Notification 503 Sunport Lane, Orlando, FL 32809 Phone: 1-866-503-0857 FAX: 1-888-267-3277 For Medicare Advantage Part B: FAX: 1-844-268-7263(All fields must be completed and return all pages for Precertification review) Please indicate: Start of treatment, start date: / / Continuation of therapy, / / date of last treatment: Precertification Requested By: Phone: Fax: A. PATIENT INFORMATION First Name: Last Name: Address: City: State: ZIP: Home Phone: Work Phone: Cell Phone: DOB: Allergies: E-mail: Current Weight: lbs or kgs Height: inches or cms B. INSURANCE INFORMATION Aetna Member ID #: Group #: Insured: Does patient have other coverage? Yes No If yes, provide ID#: Carrier Name: Insured: Medicare: Yes No If yes, provide ID #: Medicaid: Yes No If yes, provide ID #: C.

The patient has worsening disability (sustained worsening of Expanded Disability Status Scale (EDSS) score or neurological examination findings) Other (please explain):

Loading..

Tags:

  Scale, Medication, Request, Status, Disability, Precertification, Expanded, Medication precertification request, Ocrelizumab, Expanded disability status scale

Information

Related search queries